APA (7th ed.) Citation

Burstein, H. J., Keshaviah, A., Baron, A. D., Hart, R. D., Lambert-Falls, R., Marcom, P. K., . . . Winer, E. P. (2007). Trastuzumab Plus Vinorelbine or Taxane Chemotherapy for HER2-overexpressing Metastatic Breast Cancer: The Trastuzumab and Vinorelbine or Taxane Study. Cancer (0008543X), 110(5), 965. https://doi.org/10.1002/cncr.22885

Chicago Style (17th ed.) Citation

Burstein, Harold J., Aparna Keshaviah, Ari D. Baron, Ronald D. Hart, Rosemary Lambert-Falls, P. Kelly Marcom, Rebecca Gelman, and Eric P. Winer. "Trastuzumab Plus Vinorelbine or Taxane Chemotherapy for HER2-overexpressing Metastatic Breast Cancer: The Trastuzumab and Vinorelbine or Taxane Study." Cancer (0008543X) 110, no. 5 (2007): 965. https://doi.org/10.1002/cncr.22885.

MLA (9th ed.) Citation

Burstein, Harold J., et al. "Trastuzumab Plus Vinorelbine or Taxane Chemotherapy for HER2-overexpressing Metastatic Breast Cancer: The Trastuzumab and Vinorelbine or Taxane Study." Cancer (0008543X), vol. 110, no. 5, 2007, p. 965, https://doi.org/10.1002/cncr.22885.